Table 2.
Summary of binding studies using [125I]-VPAC2 agonist
| VPAC2 | VPAC1/2 | VPAC1+VPAC2 | |
|---|---|---|---|
| Ki (nM) | Ki (nM) | Ki (nM) | |
| VIP | 5.3±0.3 | 6.8±0.5 | 5.7±0.4 |
| VPAC1 agonist | 95±10 | 101±18 | 150±20 |
| VPAC2 agonist | 3.1±0.3 | 3.3±0.4 | 3.8±0.4 |
Results represent the means±s.e.m. of three independent experiments in duplicate.